J&J Files 2023 10-K, Details Debt Maturities

Ticker: JNJ · Form: 10-K · Filed: 2024-02-16T00:00:00.000Z

Sentiment: neutral

Topics: earnings, debt, annual-report

TL;DR

**J&J's 2023 10-K is out, showing upcoming debt maturities in 2024 and beyond.**

AI Summary

Johnson & Johnson (JNJ) filed its 10-K on February 16, 2024, for the fiscal year ended December 31, 2023. The filing details various financial instruments, including 0.650% Notes Due 2024, 5.50% Notes Due 2024, 1.150% Notes Due 2028, and 1.650% Notes Due 2035. The company's business address is One Johnson & Johnson Plaza, New Brunswick, NJ 08933.

Why It Matters

This filing provides a comprehensive overview of Johnson & Johnson's financial health and operational performance, crucial for investors to assess its stability and future prospects.

Risk Assessment

Risk Level: low — The filing is a standard annual report and does not indicate any immediate high-risk events or disclosures.

Key Numbers

Key Players & Entities

FAQ

What is the fiscal year-end for the Johnson & Johnson 10-K filing?

The conformed period of report for the Johnson & Johnson 10-K filing is December 31, 2023.

When was the Johnson & Johnson 10-K filed with the SEC?

The Johnson & Johnson 10-K was filed as of February 16, 2024.

What are some of the debt instruments mentioned in the filing and their due dates?

The filing mentions 0.650% Notes Due 2024, 5.50% Notes Due 2024, 1.150% Notes Due 2028, and 1.650% Notes Due 2035.

What is Johnson & Johnson's Central Index Key (CIK)?

Johnson & Johnson's Central Index Key (CIK) is 0000200406.

Where is Johnson & Johnson's business address located?

Johnson & Johnson's business address is One Johnson & Johnson Plaza, New Brunswick, NJ 08933.

From the Filing

0000200406-24-000013.txt : 20240216 0000200406-24-000013.hdr.sgml : 20240216 20240216161222 ACCESSION NUMBER: 0000200406-24-000013 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 158 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 24648459 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 10-K 1 jnj-20231231.htm 10-K jnj-20231231 0000200406 2023 FY false Johnson & Johnson http://fasb.org/us-gaap/2023#AccountsPayableCurrent http://fasb.org/us-gaap/2023#AccountsPayableCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense 33 0000200406 2023-01-02 2023-12-31 0000200406 us-gaap:CommonStockMember 2023-01-02 2023-12-31 0000200406 jnj:A0.650NotesDue2024Member 2023-01-02 2023-12-31 0000200406 jnj:A5.50NotesDue2024Member 2023-01-02 2023-12-31 0000200406 jnj:A1.150NotesDue2028Member 2023-01-02 2023-12-31 0000200406 jnj:A1.650NotesDue2035Member 2023-01-02 2023-12-31 0000200406 2023-07-02 iso4217:USD 0000200406 2024-02-09 xbrli:shares 0000200406 2023-12-31 0000200406 2023-01-01 iso4217:USD xbrli:shares 0000200406 2022-01-03 2023-01-01 0000200406 2021-01-04 2022-01-02 0000200406 2021-01-03 0000200406 us-gaap:RetainedEarningsMember 2021-01-03 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-03 0000200406 us-gaap:CommonStockMember 2021-01-03 0000200406 us-gaap:TreasuryStockCommonMember 2021-01-03 0000200406 us-gaap:RetainedEarningsMember 2021-01-04 2022-01-02 0000200406 us-gaap:TreasuryStockCommonMember 2021-01-04 2022-01-02 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-04 2022-01-02 0000200406 2022-01-02 0000200406 us-gaap:RetainedEarningsMember 2022-01-02 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-02 0000200406 us-gaap:CommonStockMember 2022-01-02 0000200406 us-gaap:TreasuryStockCommonMember 2022-01-02 0000200406 us-gaap:RetainedEarningsMember 2022-01-03 2023-01-01 0000200406 us-gaap:TreasuryStockCommonMember 2022-01-03 2023-01-01 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-03 2023-01-01 0000200406 us-gaap:RetainedEarningsMember 2023-01-01 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 0000200406 us-gaap:CommonStockMember 2023-01-01 0000200406 us-gaap:TreasuryStockCommonMember 2023-01-01 0000200406 us-gaap:RetainedEarningsMember 2023-01-02 2023-12-31 0000200406 us-gaap:TreasuryStockCommonMember 2023-01-02 2023-12-31 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-02 2023-12-31 0000200406 us-gaap:RetainedEarningsMember 2023-12-31 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000200406 us-gaap:CommonStockMember 2023-12-31 0000200406 us-gaap:TreasuryStockCommonMember 2023-12-31 jnj:Employee 0000200406 us-gaap:IPOMember jnj:KenvueIncMember 2023-05-08 2023-05-08 0000200406 jnj:KenvueIncMember 2023-05-08 0000200406 2023-05-08 2023-05-08 0000200406 jnj:KenvueIncMember jnj:JohnsonJohnsonMember 2023-05-08 2023-05-08 xbrli:pure 0000200406 jnj:KenvueIncMember jnj:JohnsonJohnsonMember 2023-07-02 0000200406 jnj:KenvueIncMember 2023-08

View on Read The Filing